Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Gonzalez-Calle V, Rodriguez-Otero P, Calasanz MJ, Guijarro M, Martinez-Lopez J, Rosinol L, Hernandez MT, Teruel AI, Gironella M, Oriol A, de la Rubia J, Gonzalez-Rodriguez AP, Bargay J, de Arriba F, Palomera L, Gonzalez-Perez MS, Sureda A, Ocio E, Lahuerta JJ, Blade J, San Miguel JF, Mateos MV, Gutierrez NC. High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience. Hemasphere. 2024 Dec 10;8(12):e70031. doi: 10.1002/hem3.70031. eCollection 2024 Dec. PubMed PMID: 39665068; PubMed Central PMCID: PMC11632121.
AÑO: 2024; IF: 14.6
39665068
Pinana JL, Tridello G, Xhaard A, Wendel L, Montoro J, Vazquez L, Heras I, Ljungman P, Mikulska M, Salmenniemi U, Perez A, Kroger N, Cornelissen J, Sala E, Martino R, Geurten C, Byrne J, Maertens J, Kerre T, Martin M, Pascual MJ, Yeshurun M, Finke J, Groll AH, Shaw PJ, Blijlevens N, Arcese W, Ganser A, Suarez-Lledo M, Alzahrani M, Choi G, Forcade E, Paviglianiti A, Solano C, Wachowiak J, Zuckerman T, Bader P, Clausen J, Mayer J, Schroyens W, Metafuni E, Knelange N, Averbuch D, de la Camara R. Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis. 2024 Jan 12;229(1):83-94. doi: 10.1093/infdis/jiad268. PubMed PMID: 37440459.
AÑO: 2024; IF: 4.5
37440459
Cuenca-Zamora EJ, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Morales ML, Lozano ML, Gonzalez-Conejero R, Martinez C, Teruel-Montoya R, Ferrer-Marin F. miR-146a-/- mice model reveals that NF-kappaB inhibition reverts inflammation-driven myelofibrosis-like phenotype. Am J Hematol. 2024 Jul;99(7):1326-1337. doi: 10.1002/ajh.27322. Epub 2024 Apr 22. PubMed PMID: 38646919.
AÑO: 2024; IF: 9.9
38646919
Mateos MV, Martinez-Lopez J, Rodriguez Otero P, Gonzalez-Calle V, Gonzalez MS, Oriol A, Gutierrez NC, Rios-Tamayo R, Rosinol L, Alvarez Rivas MA, Bargay J, Gonzalez-Rodriguez AP, Alegre A, Escalante F, Inigo Rodriguez MB, De La Rubia J, Teruel AI, de Arriba F, Palomera L, Hernandez MT, Lopez Jimenez J, Reinoso-Segura M, Garcia Mateo A, Ocio EM, Paiva B, Puig N, Cedena MT, Blade J, Lahuerta JJ, San-Miguel JF; Spanish Myeloma Group (GEM-Pethema). Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. J Clin Oncol. 2024 Sep 20;42(27):3247-3256. doi: 10.1200/JCO.23.02771. Epub 2024 Jul 22. PubMed PMID: 39038268; PubMed Central PMCID: PMC11404760.
AÑO: 2024; IF: 41.9
39038268
Arias-Martinez A, Martinez de Castro E, Gallego J, Arrazubi V, Custodio A, Fernandez Montes A, Diez M, Hernandez R, Limon ML, Cano JM, Vidal-Tocino R, Macias I, Visa L, Martin Richard M, Sauri T, Hierro C, Gil M, Cerda P, Martinez Moreno E, Martinez Lago N, Merida-Garcia AJ, Gomez Gonzalez L, Garcia Navalon FJ, Ruiz Martin M, Marin G, Lopez-Lopez F, Ruperez Blanco AB, Fernandez AF, Jimenez-Fonseca P, Carmona-Bayonas A, Alvarez-Mancenido F. Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry. Clin Transl Oncol. 2024 Jul;26(7):1674-1686. doi: 10.1007/s12094-024-03388-6. Epub 2024 Feb 15. PubMed PMID: 38361134; PubMed Central PMCID: PMC11178610.
AÑO: 2024; IF: 2.5
38361134
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL